BMN 110 Phase 3B in Australian Patients
NCT01966029
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Mucopolysaccharidosis IVA (Morquio A Syndrome)
Interventions
DRUG:
BMN 110
Sponsor
BioMarin Pharmaceutical